The versatile nature of miR-9/9(*) in human cancer

Por Nowek, Katarzyna, Wiemer, Erik A.C., Jongen-Lavrencic, Mojca
Publicado no Oncotarget (2018)

Classification of pediatric acute myeloid leukemia based on miRNA expression profiles

Por Obulkasim, Askar, Katsman-Kuipers, Jenny E., Verboon, Lonneke, Sanders, Mathijs, Touw, Ivo, Jongen-Lavrencic, Mojca, Pieters, Rob, Klusmann, Jan-Henning, Zwaan, C. Michel, van den Heuvel-Eibrink, Marry M., Fornerod, Maarten
Publicado no Oncotarget (2017)

Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation

Por Kalin, Burak, van Norden, Yvette, van Gelder, Michel, Breems, Dimitri, Maertens, Johan, Jongen-Lavrencic, Mojca, Broers, Annoek E. C., Braakman, Eric, Grob, Tim, Zeijlemaker, Wendelien, Ossenkoppele, Gert J., Meijer, Ellen, Cornelissen, Jan J.
Publicado no Blood Adv (2020)

Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia

Por Hirsch, Susanne, Blätte, Tamara J., Grasedieck, Sarah, Cocciardi, Sibylle, Rouhi, Arefeh, Jongen-Lavrencic, Mojca, Paschka, Peter, Krönke, Jan, Gaidzik, Verena I., Döhner, Hartmut, Schlenk, Richard F., Kuchenbauer, Florian, Döhner, Konstanze, Dolnik, Anna, Bullinger, Lars
Publicado no Haematologica (2017)

Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

Por Löwenberg, Bob, Muus, Petra, Ossenkoppele, Gert, Rousselot, Philippe, Cahn, Jean-Yves, Ifrah, Norbert, Martinelli, Giovanni, Amadori, Sergio, Berman, Ellin, Sonneveld, Pieter, Jongen-Lavrencic, Mojca, Rigaudeau, Sophie, Stockman, Paul, Goudie, Alison, Faderl, Stefan, Jabbour, Elias, Kantarjian, Hagop
Publicado em 2011

Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP

Por Hatzl, Stefan, Geiger, Olivia, Kuepper, Maja Kim, Caraffini, Veronica, Seime, Till, Furlan, Tobias, Nussbaumer, Erika, Wieser, Rotraud, Pichler, Martin, Scheideler, Marcel, Nowek, Katarzyna, Jongen-Lavrencic, Mojca, Quehenberger, Franz, Wölfler, Albert, Troppmair, Jakob, Sill, Heinz, Zebisch, Armin
Publicado no Cancer Res (2016)

CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping

Por Bras, Anne E., de Haas, Valerie, van Stigt, Arthur, Jongen‐Lavrencic, Mojca, Beverloo, H. Berna, te Marvelde, Jeroen G., Zwaan, C. Michel, van Dongen, Jacques J.M., Leusen, Jeanette H.W., van der Velden, Vincent H.J.
Publicado no Cytometry B Clin Cytom (2018)

MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1–regulated pathways in mice

Por Meenhuis, Annemarie, van Veelen, Peter A., de Looper, Hans, van Boxtel, Nicole, van den Berge, Iris J., Sun, Su M., Taskesen, Erdogan, Stern, Patrick, de Ru, Arnoud H., van Adrichem, Arjan J., Demmers, Jeroen, Jongen-Lavrencic, Mojca, Löwenberg, Bob, Touw, Ivo P., Sharp, Phillip A., Erkeland, Stefan J.
Publicado em 2011

The non-coding RNA landscape of human hematopoiesis and leukemia

Por Schwarzer, Adrian, Emmrich, Stephan, Schmidt, Franziska, Beck, Dominik, Ng, Michelle, Reimer, Christina, Adams, Felix Ferdinand, Grasedieck, Sarah, Witte, Damian, Käbler, Sebastian, Wong, Jason W. H., Shah, Anushi, Huang, Yizhou, Jammal, Razan, Maroz, Aliaksandra, Jongen-Lavrencic, Mojca, Schambach, Axel, Kuchenbauer, Florian, Pimanda, John E., Reinhardt, Dirk, Heckl, Dirk, Klusmann, Jan-Henning
Publicado no Nat Commun (2017)

MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia

Por Gentner, Bernhard, Pochert, Nicole, Rouhi, Arefeh, Boccalatte, Francesco, Plati, Tiziana, Berg, Tobias, Sun, Su Ming, Mah, Sarah M., Mirkovic-Hösle, Milijana, Ruschmann, Jens, Muranyi, Andrew, Leierseder, Simon, Argiropoulos, Bob, Starczynowski, Daniel T., Karsan, Aly, Heuser, Michael, Hogge, Donna, Camargo, Fernando D., Engelhardt, Stefan, Döhner, Hartmut, Buske, Christian, Jongen-Lavrencic, Mojca, Naldini, Luigi, Humphries, R. Keith, Kuchenbauer, Florian
Publicado no Exp Hematol (2015)

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS

Por Huls, Gerwin, Chitu, Dana A., Pabst, Thomas, Klein, Saskia K., Stussi, Georg, Griskevicius, Laimonas, Valk, Peter J. M., Cloos, Jacqueline, van de Loosdrecht, Arjan A., Breems, Dimitri, van Lammeren-Venema, Danielle, van Zeventer, Isabelle, Boersma, Rinske, Jongen-Lavrencic, Mojca, Fehr, Martin, Hoogendoorn, Mels, Manz, Markus G., Söhne, Maaike, van Marwijk Kooy, Rien, Deeren, Dries, van der Poel, Marjolein W. M., Legdeur, Marie Cecile, Tick, Lidwine, Chalandon, Yves, Ammatuna, Emanuele, Blum, Sabine, Löwenberg, Bob, Ossenkoppele, Gert J.
Publicado no Blood Adv (2020)